Characterization Novel Class Transcription Factor (CITFA)
Subunit Indispensable Transcription Multifunctional RNA Polymerase Trypanosoma brucei
Tu N. Nguyen Bao N. Nguyen Ju Huck Lee  Aswini K. Panigrahi,c* Arthur GÃ¼nzla,b
Department Genetics Developmental Biology, University Connecticut Health Center, Farmington, Connecticut, USAa; Department Molecular, Microbial Structural Biology, University Connecticut Health Center, Farmington, Connecticut, USAb; Seattle Biomedical Research Institute, Seattle, Washington, USAc

Trypanosoma brucei organism known evolved multifunctional RNA polymerase (pol  used express parasiteâ€™s ribosomal RNAs, major cell surface antigens,  variant surface glycoprotein
(VSG) procyclin, vital establishing successful infections mammalian host tsetse vector, respec-
tively. far, biochemical analyses T. brucei RNA pol transcription machinery elucidated subunit structure enzyme identified class transcription factor (CITFA). CITFA binds RNA pol promoters, CITFA-2
subunit shown absolutely essential RNA pol transcription parasite. Tandem affinity purification (TAP) CITFA revealed subunits CITFA-1 -6, conserved kinetoplastid organisms, plus dynein light
chain DYNLL1.  tagging CITFA-6 instead CITFA-2, complex purified contained known CITFA subunits, novel proline-rich protein. Functional studies carried vivo vitro, colocalization study, 
equivocally demonstrated protein bona fide CITFA subunit, essential parasite viability indispensable RNA pol transcription ribosomal gene units active VSG expression site mammalian-infective life cycle stage parasite. Interestingly, CITFA-7 function appears species specific, expression RNA interference (RNAi)-
resistant CITFA-7 transgene Trypanosoma cruzi rescue lethal phenotype silencing endogenous CITFA-7.


  n eukaryotes, RNA polymerase (pol  transcribes exclusively
   large ribosomal gene units nucleolus. unicellular
parasite Trypanosoma brucei exceptional regard                                                                                    RNA pol allows parasite express VSG                                                                                    single gene. mammals RNA pol unable synthesize
                                                                                   functional mRNA (5), deviating gene expression mechanisms organism known evolved multifunctional                    trypanosomatids enables T. brucei use RNA pol RNA pol used rRNA synthesis                       mRNA synthesis. trypanosomatids, protein-coding genes expression proteins crucial parasiteâ€™s successful              arranged long tandem arrays transcribed polycis-
interaction hosts. T. brucei tsetse-borne parasite                tronically, RNA precursors resolved individual
sub-Saharan Africa causes lethal diseases humans live-                 mRNAs spliced leader (SL) trans splicing polyadenylation
stock animals (2). lives freely mammalian bloodstream                 (reviewed reference 6). eukaryotes, mRNA cap-
virtue dense coat variant surface glycoprotein (VSG)                 ping occurs cotranscriptionally direct interaction cap-
shields invariant membrane proteins immune recognition                        ping enzymes RNA pol II, SL trans splicing, (32) antigenic variation enables parasite evade                   capped, 5=-terminal SL RNA fused 5= end hostâ€™s immune  â¬ƒ10 million VSG copies                      mRNA, uncouples capping RNA pol II transcription, surface bloodstream-form (BF) trypanosome,                   enabling T. brucei RNA pol express functional mRNA expressed single gene drawn repertoire                  (26, 37).
2,000 VSG genes (16). accommodate dense coat, active                        multifunctional RNA pol T. brucei versatile.
VSG gene, resides 15 telomeric expression sites                    eukaryotes RNA pol confined nucleolus,
(ESs) (11), needs transcribed extremely high rates;                transcribes rRNA gene units (RRNAs), active VSG ES
estimated VSG RNA synthesis active ES exceeds                   transcribed outside nucleolus (3) extranucleolar ex- single â?¤-tubulin gene â¬ƒ50-fold (4). high VSG expres-                  pression site body (ESB), DNase-resistant compartment sion required antigenic variation essential BF              appears limit productive transcription single site (17). viability itself, VSG silencing led rapid block trypano- proliferation culture clearance parasites 
fected mice (33).                                                                     Received 11 September 2012 Accepted 22 October 2012
    eukaryotic cells, RNA pol transcription typically accounts                   Published ahead print 26 October 2012 50  total transcriptional activity,                     Address correspondence Arthur GÃ¼nzl, gunzl@uchc.edu. number ribosomal gene units far lower number                       * Present address: Ju Huck Lee, Harvard Medical School, Boston, Massachusetts, protein-coding genes. efficiency RNA pol                      USA; Aswini K. Panigrahi, KAUST, Thuwal, Saudi Arabia.
appears result high transcription initiation rates,                      Supplemental material article http://ec.asm.org/. impressively documented transmission elec-                         Copyright Â© 2012, American Society Microbiology. Rights Reserved.
tron microscopy called â€œMiller spreadsâ€? (reviewed refer-                     doi:10.1128/EC.00250-12
ence 28). likely high efficiency 

December 2012 Volume 11 Number 12                                             Eukaryotic Cell   p. 1573â€“1581                                            ec.asm.org     1573
 Nguyen et al.



addition VSG expression, parasite utilizes RNA pol           untranslated region (UTR) (positions 409 941 relative translation
insect-stage, procyclic form (PF) transcription gene loci         initiation codon) vector pT7-stl (1). Allele deletions (25) encode types cell surface antigen procyclin.           achieved transfecting PCR products 100 bp 5= 3= gene
Procylins important parasite establish successful             flanks fused hygromycin phosphotransferase coding region.
infections tsetse vector (27). RRNA, VSG ES, pro-                 following DNA oligonucleotides used reverse transcription
                                                                             (RT)-PCR: CITFA-7, 5=-TAGGGCCCAGCAACCTTGCCTGCTATATTA
cyclin gene promoters structurally different, suggesting                                                                              CTTGATACC-3=/5=-TAGGTACCTTGCACTCCTGCGTCGGCCGTGA recruit different transcription factors (9).                                                                              GC-3=; CITFA-2, 5=-ATAACTCGGAGACTGACTCG-3=/5=-AACTGGT
promoters absent trypanosomatid organisms Trypano-                GTATTGAACAACG-3=; CITFA-6, 5=-AGAAGCTTACGCGTATGGCT
soma cruzi Leishmania spp., expect T. bru-             GTACAACCGGGAAAGGTG-3=/5=-AGTCTAGACTCGAGGTTATGT
cei-specific proteins VSG ES procyclin gene transcription.           ACCTGAATCCAGCTGTC-3=; Tb927.7.2590, 5=-TCGAGCAACTTGAA  proteins involved T. brucei RNA pol transcrip-             GAGTTACG-3=/ 5=-TCCTGTGGCTTCTGTTCGTTGG-3=; TFIIB, 5=-C
tion far conserved trypanosomatids, suggesting              ACCTCGACTACCACAGATTT TGTTGGGC-3=/5=-TGGTGATCAACG fulfill general RNA pol functions. Alternatively,          TCCTCATACGTGG-3=; TcCITFA-7, 5=-CCTCCCTTTAGCTGCGATG
possible common transcription factors gained specific             CCTAATGTGCGCCGTTGTCGTTGG-3=/5=-TAGCGGCCGCTCCGA
functions protein-coding gene transcription T. brucei evo-            TGACAACTCATTTCCCTCTTG-3=; VSG221, 5=-AGCTTTTTGGCAAC
lution.                                                                      CTCTTTGCCAGG-3=/5=-TGGTAACGCCTGTTTTGCCAGCTATTCC-3=.
    Bioinformatic biochemical analysis T. brucei RNA pol                Cells. BFs cultured HMI-9 medium described previously
                                                                             (22). stable BF transfection, 3 â«» 107 cells, grown exponential phase,
revealed 10 12 core subunits present nuclear
                                                                             washed 2 ml Cytomix (120 mM KCl, 0.15 mM CaCl2, 10 mM
RNA Pol (13, 19, 35). notion missing ortholog                                                                              K2HPO4, 25 mM HEPES-KOH, pH 7.6, 2 mM EDTA, 5 mM MgCl2),
essential yeast RPA43 subunit replaced T. brucei          resuspended 0.4 ml Cytomix, mixed 10 â?®g linearized plas-
RNA pol II paralog RPB7 (13) substantiated (22).                mid DNA 5 â?®g PCR product. Cells electroporated 1.2 kV, 186
Instead, essential RNA pol subunit, termed T. brucei RPA31              â?€, 50 â?®F BTX ECM600 electroporator, immediately resuspended (TbRPA31), novel subunit extremely diver-            50 ml 37Â°C prewarmed medium, dispensed 1-ml aliquots gent ortholog yeast RPA43, (18). Recently, class          24 plates. incubation overnight, 1 ml antibiotic-contain-
transcription factor (CITFA) identified; purification led          ing medium added  Cells selected using G418, identification novel subunits, termed CITFA-1 -6,           phleomycin, hygromycin, blasticidin final concentrations 2.5, 1, 1,
plus dynein light chain DYNLL1  known LC8) (1).                  2 â?®g/ml, respectively. PF culturing transfection carried Tandem affinity-purified CITFA bound 67-bp-long VSG ES                described previously (8, 14).
promoter electrophoretic mobility shift assay, requiring                   vitro transcription. Preparation transcriptionally active extracts
                                                                             cotranscription reactions BES promoter template VSG-trm upstream promoter elements efficient binding. gel
                                                                             RNA pol II-recruiting control template SLins19 carried shift competed RRNA procyclin gene promot-
                                                                             described previously (14). immunodepletion CITFA-2 ers, indicating CITFA general factor RNA pol tran-           CITFA-7 transcription reactions, extracts prepared cells
scription T. brucei. Accordingly, silencing CITFA-2 expression            exclusively expressing PTPâ€“CITFA-2 (1) CITFA-7â€“PTP depleted lethal specifically reduced rRNA VSG mRNA abun-                  IgG beads (GE Healthcare). parallel, extracts mock treated
dances BFs.  vitro transcription assays unequivo-             beads. Transcription signals obtained primer extension
cally demonstrated CITFA-2 absolutely required                  32P-end-labeled oligonucleotides Tag-PE SLtag, hybrid-
transcription types RNA pol promoters (1).               ize unrelated oligonucleotide insertions VSG-trm SLins19
    identified novel, proline-rich protein            RNAs, respectively. Primer extension products separated 
purified CITFA-6 extract. protein known                 naturing 50  ureaâ€“ 6  polyacrylamide gels detected autora-
protein domains conserved trypanosomatids.                 diography. data protein bona fide CITFA subunit                 RNA analysis. Total RNA preparation hot phenol method                                                                              Northern blot primer extension analyses carried previ-
essential RRNA VSG transcription BFs. Interestingly,
                                                                             ously described (1, 18). Reverse transcription total RNA using
CITFA-7 silencing rescued RNA interference (RNAi)-                 SuperScript II reverse transcriptase (Invitrogen), following manufac-
resistant T. brucei CITFA-7 (TbCITFA-7) transgene             turerâ€™s recommendations.
heterologous T. cruzi ortholog (TcCITFA-7). data sug-                  Antibodies. generation immune sera, length CITFA-6
gest TcCITFA-7 generally defective T. brucei, ex-           CITFA-7 recombinantly expressed Escherichia coli periment confirmed previous observations mammals es-                 N-terminal glutathione S-transferase (GST) tag purified glutathi-
sential functions RNA pol transcription diverge rapidly            affinity chromatography. GST fusion proteins used im-
(10).                                                                        munizing rats published previously (29). addition immune
                                                                             sera, immunoblot detections carried polyclonal antibodies
MATERIALS METHODS                                                        directed CITFA-2 (1), TFIIB (29), spliceosomal protein
DNAs. pCITFA-6-PTP-NEO described previously (1). pCITFA-7-               U2A=  known U2-40K [20]). PTP tag detected PTP-NEO pCITFA-7-HA-BLA generated inserting 353 bp            monoclonal anti-protein C epitope antibody (Roche)  CITFA-7 coding region (position 56 position 408) ApaI    oxidase antiperoxidase reagent (Sigma). hemagglutinin (HA) tag 
NotI sites vectors pC-PTP-NEO (31) pC-HA-BLA (18), respec-            tection, rat monoclonal anti-HA antibody used (Roche).
tively.  pTcCITFA-7-HA-bla, 543 bp T. brucei CITFA-7 5=            Protein analysis. Extract preparation CITFA-6-P CITFA-7-
gene flank fused T. cruzi CITFA-7 open reading frame (ORF)     PTP tandem affinity purifications conducted according stan-
overlap PCR. product cloned vector pC-HA-BLA                dard protocol (31). Purified proteins separated SDSâ€“10 20  ApaI NotI sites. construct linearized MscI site   polyacrylamide gradient gels stained Coomassie blue (Gelcode integration T. brucei CITFA-7 locus. RNAi vector            Coomassie stain; Thermo Fisher Scientific). protein identification,
pCITFA-7-T7-stl generated inserting 533 bp CITFA-7 3=          protein bands excised gels, digested trypsin, subjected


1574   ec.asm.org                                                                                                                          Eukaryotic Cell
                                                                                                                               Novel CITFA Subunit T. brucei




FIG 1 Identification CITFA-7.   Tandem affinity purification CITFA-6 â€“PTP. Purified proteins separated SDS-PAGE stained Coomassie blue. comparison, 0.002  crude extract (Inp) 5  TEV protease eluate coanalyzed. right, mass spectrometric protein
identifications CITFA-1 -7, DYNLL1, CITFA-2 degradation products (2-deg) indicated. (B) Reciprocal IP CITFA-7â€“HA PTPâ€“CITFA-2 PF BF extracts. immunoblot analysis includes equal amounts starting material (Inp) supernatant (S) 5-fold enrichment precipitate (P). Detection RNA pol II transcription factor TFIIB served negative control. (C) Multiple sequence alignment trypanosomatid CITFA-7
orthologs T. brucei (accession numbers listed Table S1 supplemental material), T. congolense (Tco), T. vivax (Tv), T. cruzi (Tc), Leishmania
major (Lm), L. infantum (Li), L. braziliensis (Lb). Positions 50  identity similarity shaded black gray, respectively. Overall
identity/similarity values specified end sequence determined pairwise comparison T. brucei sequence using EMBOSS software
program (http://www.ebi.ac.uk/emboss/align/) default settings. Dashes indicate sequence gaps. Numbers parentheses specify number residues significant sequence similarity. Asterisks mark 13 invariant proline positions.

 liquid chromatography-tandem mass spectrometry. resulting data            RESULTS analyzed using TurboSEQUEST program BioWorks 3.1                 Identification novel CITFA subunit. CITFA originally
software package (Thermo Fisher Scientific). Coimmunoprecipitations              characterized tandem affinity purification tagged CITFA-2.
 IPs) carried previously published (18), BF extract
                                                                                 confirm nature complex, tandem affinity prepared recently described (21). Sucrose sedimentation 
formed exactly previously procyclic extract (1).
                                                                                 purified conserved subunit, CITFA-6,      Immunofluorescence microscopy. BFs grown exponential phase               C-terminally fused composite PTP tag consisting tan- centrifuged 800 â«» g 5 min, washed ice-cold phosphate-             dem protein (ProtA) domain, TEV protease cleavage site, buffered saline (PBS), fixed adding formaldehyde final           protein C epitope (ProtC [31]). CITFA-1 -6 DYNLL1
centration 2  10 min room temperature. Fixation termi-             recovered final eluate addition fainter bands
nated adding glycine final concentration 125 mM 5 min.            35 kDa band â¬ƒ17.5 kDa (Fig. 1A). Liquid
Cells washed times PBS resuspended PBS          chromatography-tandem mass spectrometry revealed density 3 â«» 107 cells/ml. Cells (5 â«» 106) spotted silanized         larger bands specific degradation products CITFA-2,
coverslips (Thermo Fisher Scientific) allowed settle 30 min,          17.5-kDa band identified new protein coverslips washed twice PBS 5 min                                                                                   termed CITFA-7 (accession number Tb927.7.2600).
reduce spherical aberrations cells, coverslips placed 24 plate centrifuged 2 min 800 â«» g (12). 10-min rehydra-             apparent size CITFA-7 range tion PBS, fixed cells permeabilized 0.1  NP-40-containing PBS         predicted mass 15.1 kDa, identification based exactly 5 min, washed twice PBS, blocked PBG (PBS containing           single, partially tryptic peptide match (data shown). 
0.5  bovine serum albumin [BSA] 0.2  cold water fish gelatin;                firm correct protein identified, generated PF Sigma), incubated consecutively primary secondary anti-             BF cell lines CITFA-2 -7 PTP HA tagged,
bodies diluted PBG. Coverslips extensively washed PBS         respectively. Reciprocal coimmunoprecipitation  IP) assays antibody probing finally mounted slide VectaShield          extracts prepared cells unequivocally demon-
(Vector lab). PTP-tagged proteins detected polyclonal anti-          strated interaction proteins (Fig. 1B). protein immune serum (Sigma) followed Alexa 594-conjugated               C terminus, CITFA-7â€™s amino acid sequence highly 
anti-rabbit secondary antibody (Invitrogen), HA-tagged CITFA-7
                                                                                 served members Trypanosomatidae se- detected specified anti-HA antibody Alexa
488-conjugated anti-rat secondary antibody (Invitrogen). Immunofluo-             quence similarity proteins outside phylogenetic family.
rescence assays procyclics described previously (15). Im-        Furthermore, CITFA-7 does contain sequence motifs ages acquired Zeiss AxioVert 200 microscope, colocaliza-           known function does contain 13 proline residues tions quantified using Zeiss Axiovision 4.6.3.0 colocalization          absolutely conserved trypanosomatid orthologs (Fig. 1C).
software program.                                                                    CITFA-7 bona fide subunit CITFA. CITFA-7 

December 2012 Volume 11 Number 12                                                                                                             ec.asm.org 1575
 Nguyen et al.




FIG 2 CITFA-7 bona fide subunit CITFA.   Schematic drawing CITFA-7 wild-type (WT) allele allele modifications cell line TbC7ee, exclusively expresses CITFA-7â€“PTP untagged CITFA-7. CITFA-7 coding region, HYGR NEOR genes, PTP tag sequence depicted open boxes, striped boxes, black box, respectively. Gene flanks RNA processing signals indicated smaller gray boxes. (B) Immunoblot
analysis cell lysates wild-type procyclic cells TbC7ee cells using newly generated polyclonal anti-CITFA-7 immune serum (â?£ CITFA-7) commercially available (Roche), monoclonal anti-ProtC antibody (â?£ ProtC). (C) Immunoblot monitoring CITFA-7â€“PTP purification (note TEV
protease digest reduced CITFA-7â€“PTP CITFA-7â€“P). Aliquots crude extract (Inp), flowthrough IgG affinity chromatography (FT-IgG), TEV
protease elution (TEV), flowthrough anti-ProtC affinity chromatography (FT-ProtC), final eluate (Elu) separated 10  SDS-
polyacrylamide gel, blotted, probed anti-ProtC antibody. blot reprobed immune sera directed CITFA-2 CITFA-6. Arrows
point FT-IgG signals indicating codepletion subunits. (D) Protein analysis CITFA-7 TAP, analogous CITFA-6 TAP Fig. 1A. (E) Anti-ProtC
immunoblot final eluate CITFA-7â€“PTP purification. purified complex left untreated incubated alkaline phosphatase (AP)  calf intestine) AP phosphatase inhibitor cocktail (ph-inh).


 detected CITFA-2 tandem affinity purification (1)                   faint band just main band resolved,
purified CITFA-6 substoichiometric amounts (Fig. 1A),                 suggesting CITFA-7 carries modification possible represented distinct factor interacted               phosphates. CITFA complex. explore possibility, tagged                      Monitoring PTP tandem affinity purification immuno- tandem affinity purified CITFA-7. generated PF cell               blotting showed CITFA-7â€“PTP, reduced line, termed TbC7ee, exclusively expressed CITFA-7                  CITFA-7â€“P TEV protease elution, efficiently purified C-terminal PTP tag. achieved integrating plasmid                 chromatography steps (Fig. 2C, upper panel). blot
pCITFA-7-PTP-NEO CITFA-7 allele knocking                         shown Fig. 2C reprobed polyclonal anti-CITFA-2 remaining CITFA-7 wild-type allele hygromycin                   antibody (1), apparent CITFA-2 efficiently
phosphotransferase (HYGR) marker (Fig. 2A). molecular                       codepleted extract (Fig. 2C, middle panel, arrow). tool, raised specific anti-CITFA-7 immune serum rats                 analyze finding extended CITFA subunits,
confirmed TbC7ee cells did express wild-type, untagged                  raised specific polyclonal anti-CITFA-6 immune serum CITFA-7 (Fig. 2B). CITFA-7 encoded essential gene                 rats  Fig. S1 supplemental material). Reprobing blot
 , concluded tag did interfere                    antiserum showed codepletion CITFA-6 (Fig.
CITFA-7 function. anti-ProtC anti-CITFA-7 antibodies                    2C, lower panel). follows, CITFA complex quantitatively
detected wild-type tagged CITFA-7 distinct, nar-                associated tagged CITFA-7. Furthermore, protein profile
rowly spaced bands. pattern primarily result multiple             CITFA-7 purification revealed CITFA sub-
CITFA-7 phosphorylations, treatment alkaline phos-                    units copurified apparently stoichiometric amounts, phatase resolved larger bands lower band (Fig. 2E).                 major protein bands detectable (Fig. 2D). concluded


1576   ec.asm.org                                                                                                                                 Eukaryotic Cell
                                                                                                                                   Novel CITFA Subunit T. brucei




FIG 3 CITFA-7 silencing lethal, leading specific loss RNA pol synthesized transcripts.   Growth curves clonal BF cell line absence (-Dox,
blue) presence (â«¹Dox, red) doxycyline,  line, induces synthesis CITFA-7 dsRNA targets 3= UTR corresponding mRNA. lethal phenotype presence doxycycline rescued (Rescue â«¹Dox, green) fusing HA tag sequence RPA1 3= UTR endogenous
CITFA-7 allele. schematic wild-type modified CITFA-7 mRNAs  scale), coding region depicted gray box wild-type UTRs black lines, capped spliced leader drawn cyan, poly  tail indicated AAA. modified mRNA, HA coding sequence modified 3= UTR drawn green. (B) Semiquantitative RT-PCR analysis CITFA-7, CITFA-2, CITFA-6 mRNA levels total RNA prepared cells CITFA-7 silenced specified periods. addition, mRNA abundance gene Tb927.7.2590, downstream, tandemly linked gene CITFA-7, TFIIB, independent control, determined. post ind., postinduction. (C) Anti-HA immunoblot analysis cell lysates prepared rescued
cells induced doxycycline specified periods expressed CITFA-7â€“HA RNAi-resistant mRNA. U2A= detection blot
served loading control. (D) Analysis total RNA prepared CITFA-7-silenced cells. rRNA detected ethidium bromide staining, VSG mRNA mRNA spliceosomal protein SmD1 Northern blotting, SL RNA U2 snRNA primer extension analysis.


 CITFA-7 bona fide subunit CITFA complex.                       gene modification achieved targeted integration plas-
appears tagging CITFA-2 lesser extent tagging                  mid CITFA-7 locus fused HA tag sequence CITFA-6 destabilized CITFA-7 binding CITFA complex,                         3= flank gene encoding largest RNA pol subunit RPA1
leading partial losses CITFA-7 corresponding purifi-                  CITFA-7 allele. shown Fig. 3C, abundance cations.                                                                           HA-tagged CITFA-7 did decrease doxycycline induc-
    CITFA-7 essential trypanosome viability RNA pol                     tion. concluded CITFA-7 essential mediated gene expression. address CITFA-7                       viability BFs. essentiality CITFA-7 appears extend essential component CITFA, silenced CITFA-7 expression                       PFs  corresponding knockdown life cycle BFs conditional, doxycycline-induced expression                           stage halted culture growth 3 days  Fig. S2 supple-
CITFA-7 double-stranded RNA (dsRNA) (36), targeting 3=                         mental material).
UTR CITFA-7 mRNA RNAi pathway. obtained                              analysis total RNA prepared CITFA-7-silenced single clonal cell line proliferation ceased 1 day            BFs showed RNA pol transcripts rRNA VSG mRNA doxycycline induction, noninduced cells prolifer-                   abundant doxycycline induction (Fig. 3D). ated logarithmically 3-day period experi-                    samples containing equal amounts RNA, compensa-
ment (Fig. 3A). lethal phenotype appeared                         tory increases relative abundance observed RNA
CITFA-7 silencing CITFA-7 mRNA level strongly                      pol II-synthesized SmD1 mRNA, encoding RNA splicing pro-
reduced 24 h doxycycline induction mRNA abun-                        tein, SL RNA, RNA pol III-synthesized U2
dances gene downstream adjacent CITFA-7                       snRNA. corresponding results obtained loss CITFA-2, CITFA-6, TFIIB control affected (Fig.                    CITFA-2 (1) RNA pol subunit RPA31 (18), profile 3B). unequivocally demonstrate lethal effect spe-                  RNA abundances strongly indicated CITFA-7 essential cific CITFA-7 silencing opposed nonspecific target                  RNA pol transcription.
siRNA effect, manipulated CITFA-7 allele â€œRNAiâ€?                          CITFA-7 colocalizes CITFA-2 RNA pol subunit
cell line create RNAi-resistant CITFA-7 mRNA fully                     RPB6z nucleolus. far, localization CITFA sub-
restored cell growth presence doxycycline (Fig. 3A).                 units investigated. facilitate analysis, 

December 2012 Volume 11 Number 12                                                                                                                 ec.asm.org 1577
 Nguyen et al.




FIG 4 CITFA-7 colocalizations.   Colocalization PTP-RPB6z (red) CITFA-7â€“HA (green). (B) Colocalization PTPâ€“CITFA-2 (red) CITFA-
7â€“HA (green). White bars represent 10 â?®m.
                                                                            FIG 5 CITFA-7 essential RNA pol transcription. Cotranscriptions                                                                             VSG ES promoter template VSG-trm RNA pol II control template SLins19
                                                                            extracts mock depleted (mock), immunodepleted (depl)                                                                             CITFA-2 CITFA-7, reconstituted buffer final eluates (elu) generated BF cell lines CITFA-7 C-ter-             PTPâ€“CITFA-2 CITFA-7â€“PTP TAPs  panel). Anti-CITFA-2 (middle
minally HA tagged RPB6z CITFA-2 N-termi-                  panel) anti-CITFA-7  panel) immunoblots depleted recon-
nally PTP tagged. tags functional, exclusive           stituted extracts detecting endogenous, PTP-tagged, P-tagged  TEV
expression tagged versions essential proteins did           protease digest) proteins shown. impair proliferation cultured trypanosomes (1, 18; study). 4=,6-diamidino-2-phenylindole (DAPI) stains nucleus, nucleolus recognized spherical structure        concentrated nucleolus ESB (Fig. 4B, second panel
low DNA density (Fig. 4). expected, RNA pol subunit                set; data shown).
RPB6z localized consistently nucleolus, cases               CITFA-7 depletion extract abolishes RNA Pol tran- accumulation nucleolar periphery (Fig. 4A),           scription vitro. verify essential transcription function observed (23). tagged CITFA-7 subunit exhibited                CITFA-7, depleted CITFA-7 extracts prepared similar distribution, colocalization CITFA-7 RPB6z               TbC7ee cells. Cotranscription VSG ES promoter template calculated approximately 50  protein  Fig.           VSG-trm RNA pol II-recruiting template SLins19, har-
S3 supplemental material). partial overlap consistent        boring SL RNA gene promoter, showed depletion CITFA promoter-binding transcription initiation                CITFA-7 extract virtually abolished VSG-trm transcription
factor associated transcribing RNA pol  ex-               affecting SLins19 transcription (Fig. 5, compare lanes 5
pected, colocalization CITFA-7 CITFA-2 (Fig. 4B) showed              6). result mirrored depletion CITFA-2 extract greater overlap. colocalization signal pro-         prepared cells exclusively expressed tagged CITFA-2
teins comprised 80  CITFA-2 signal 63                     (lanes 1 2). Previously, reported RNA pol transcrip-
CITFA-7 signal  Fig. S4), supporting conclusion                tion CITFA-2-depleted extract partially restored
CITFA-7 bona fide subunit CITFA complex.                    addition CITFA complex purified tagged
greater, noncolocalized CITFA-7 signal indicate            CITFA-2 (1);  result reproduced CITFA-2-
CITFA complexes carry CITFA-2 subunit  .                      CITFA-7-depleted extracts (lanes 3 7). contrast, add-
    hands, detection ESB difficult, ob-            ing CITFA purified tagged CITFA-7 resulted served extranucleolar spots 10  cells (n â«½ 174).            restoration VSG-trm transcription (lanes 4 8). Detec-
Interestingly, spots observed RPB6z                tion CITFA-2 CITFA-7 proteins depleted 
CITFA subunit localizations. rare cases, CITFA-7 colocal-          stored extracts showed amounts proteins added ized RPB6z CITFA-2 outside nucleolus, raising            extract comparable respective protein levels mock- possibility transcription initiation factor CITFA           depleted extracts (Fig. 5, middle panel). 


1578   ec.asm.org                                                                                                                        Eukaryotic Cell
                                                                                                                     Novel CITFA Subunit T. brucei


 immunoblots revealed CITFA-2 depletion did codeplete CITFA-7 (lane 2) CITFA-7 depletion led efficient codepletion CITFA-2 (lane 6). major differ-
ence CITFA-2 CITFA-7 purifications pres-
ence CITFA-7 complex, results confirmed CITFA-7 essential component CITFA.
    increased functionality CITFA-7-purified complex apparent electrophoretic mobility shift assay. PTPâ€“CITFA-2-purified complex, harboring little
CITFA-7, bound VSG ES promoter efficiently CITFA-7â€“PTP-purified complex  Fig. S5 supplemental
material). result indicate CITFA-7 function binding CITFA VSG ES promoter  Discussion).
    transcriptional function T. brucei CITFA-7 species
specific. Despite fact multifunctional RNA pol sys-
tem present trypanosomatids, T. cruzi, RNA pol exclusively transcribes RRNA copies eukaryotes, RNA pol CITFA subunits T. brucei conserved trypanosomatids. lack T. brucei-
specific factor raises possibility T.
brucei factors gained function evolution specific VSG ES procyclin gene expression. test possibility CITFA-7, introduced C-terminally HA-tagged T. cruzi
CITFA-7 transgene T. brucei CITFA-7 RNAi cell line conditionally expressed dsRNA CITFA-7 3= UTR (Fig. 6A). contrast equivalently tagged, RNAi-resistant T. brucei
CITFA-7â€“HA (Fig. 3A), T. cruzi CITFA-7â€“HA rescue
trypanosome proliferation (Fig. 6A), expression heterologous transgene affected mRNA (Fig.            FIG 6 Expression T. cruzi CITFA-7-HA transgene did rescue trypano-
6B) protein (Fig. 6C) levels. RNA analysis BF cell        proliferation T. brucei CITFA-7 knockdown.   Culture growth
                                                                         BFs noninduced (-Dox) TbCITFA-7-silenced (â«¹Dox) cells ex-
line showed abundances RNA pol tran-             press TcCITFA-7-HA. (B) Ethidium bromide staining rRNA semiquan-
scripts, rRNA VSG mRNA, strongly reduced                  titative RT-PCR analysis listed mRNAs 0, 24, 72 h doxycycline
TbCITFA-7 silencing (Fig. 6B), indicating TcCITFA-7â€“HA              induction. Note TbCITFA-7 mRNA targeted knockdown generally unable function T. brucei background. Al-        (KD). (C) Immunoblot analysis cell lysates prepared nonin- surprising conserved transcription factor     duced cells cells induced 24 h. TbCITFA-7 TFIIB                                                                          detected polyclonal antibodies endogenous proteins, related organism genus dysfunctional, species        TcCITFA-7â€“HA detected monoclonal anti-HA antibody. (D) Sed-
specificity function hallmark RNA pol typi-      imentation extract ultracentrifugation 10 40  linear sucrose
cally RNA pol II III systems. previously     gradient. Fractions 4 20, taken  analyzed im-
shown closely related human               munoblotting. comparison, sedimentations TEV protease (29 kDa),
                                                                         Taq DNA polymerase (95 kDa), IgG (150 kDa, 6.6S), TRF4-SNAPc-TFIIA
murine systems, factor binds ribosomal core pro-            transcription factor complex (TST) (â¬ƒ230 kDa) (30), apoferritin (AP) (444
moter, termed selectivity factor 1 (SL1) humans TIF-IB         kDa, 17S), thyroglobin (TG) (660 kDa, 19S) analyzed parallel mouse, dysfunctional s (10).            gradients (arrowheads).
    final step, wanted specific defect TcCITFA-7 T. brucei. Localization HA-tagged protein indirect immunofluorescence   microscopy           CITFA-2. notion consistent finding centrated nucleolus, expected CITFA subunit          substantial CITFA-7 signal did colocalize CITFA-2 Fig. S6 supplemental material). possibility      analysis (Fig. 4B; Fig. S4). contrast T. brucei
TcCITFA-7 did assemble CITFA complex. test            CITFA subunits, TcCITFA-7â€“HA spread  sedimented transcription extract noninduced BF             gradient exhibiting strong sedimentation peak
cells linear sucrose gradient. TbCITFA-7 detected        fractions 13 14. sedimentation pattern showed gradient unbound protein             TcCITFA-7â€“HA efficiently incorporated CITFA complex, concentrated peak fraction 13 (Fig.         CITFA complex. Formation partial CITFA complexes 
6D, middle panel). sedimentation profile TbCITFA-2             cruitment heat shock proteins incomplete protein  gradient closely resembled previous sedimentation             semblies account signal spread. alternative expla-
analysis (1), unbound protein peaking fraction 8             nation finding self-aggregation TcCITFA-7â€“HA CITFA-associated protein peaking fraction 14 (Fig. 6D,            extract.  likely, self-aggregation typ-
panel). Interestingly, finding revealed shift sedimen-   ically observed protein overexpression, avoided tation fraction gradient CITFA-7 peak,          integrating TcCITFA-7-HA transgene endogenous suggested distinct CITFA complexes           CITFA-7 locus. Furthermore, formation partial CITFA extract: inactive complex CITFA-2 active           complexes explain correct nucleolar localization 

December 2012 Volume 11 Number 12                                                                                                   ec.asm.org 1579
 Nguyen et al.



TcCITFA-7â€“HA. sum, sedimentation analysis suggested               equivalently generated CITFA-7 antibody, raised inefficient formation fully assembled CITFA complex            recombinant length protein  Materials reason TcCITFA-7â€“HA rescue silencing            Methods; data shown). exclude endogenous CITFA-7. addition, TcCITFA-7 appeared                possibility polyclonal antibody did recognize 
carry fewer posttranslational modifications TbCITFA-7 (Fig.         teraction domain CITFA-7, likely interpretation result
2B C, 3C, 6C D), contributed           CITFA-7â€™s essential interactions occur complex
failure heterologous protein function T. brucei        inaccessible antibody blockage. true, CITFA-7â€™s                                                                   main function correct assembly CITFA, notion
                                                                         supported finding CITFA-7, contrast DISCUSSION                                                               CITFA-2, CITFA complexes extract. characterized seventh nondynein subunit                    Finally, confirmed trypanosomes RNA pol CITFA termed  accordingly, CITFA-7. CITFA complex             prone rapid divergence closely related spe- essential transcription ribosomal, VSG ES,           cies. Expression heterologous CITFA-7 gene T. cruzi
procyclin gene promoters  shown VSG ES promoter,          rescue knockdown endogenous CITFA-7
binds DNA sequence-dependent fashion (1). CITFA-7            gene. data strongly indicated TcCITFA-7 unable discovered previously tagging tandem affinity            assemble functional CITFA complex showed  purification CITFA-2 copurified minute amounts                comparison TbCITFA-7, carried fewer posttranslational
CITFA-7 (1).  data clearly demonstrated            modifications. Interestingly, defect murine CITFA-7 bona fide CITFA subunit essential proper        human RNA pol systems attributed rapid divergence
function protein complex. showed CITFA-7             rDNA promoter sequence DNA-protein interaction tagged depleted extract, trackable             core factors (10), results suggest Tc-
CITFA subunits, 2 6, codepleted extracts, indicat-         CITFA-7 unable undergo correct complex assembly ing subunits quantitatively bound CITFA-7.        obtain potentially important posttranslational modifications.
Consistent CITFA-7 CITFA subunit, knockdown             dramatic defects trypanosomes likely 
specifically affected abundance RNA pol transcripts         sequence changes amino acid sequences trypano-
rRNA VSG mRNA.  vitro assays unequivo-               somatid transcription factors diverged rapidly
cally demonstrated importance CITFA-7 CITFA func-              example, trypanosomatid RNA processing factors (6,
tion: CITFA-2-purified complex, comprised CITFA                7).  approach reconstituting CITFA function
subunits CITFA-7, efficient CITFA-7-           vivo heterologous subunits subunit domains purified complex restoring RNA pol transcription CITFA-          potential uncover VSG procyclin gene-specific functions depleted extracts binding VSG ES promoter gel shifts.      essential RNA pol transcription factor complex.
    specific function CITFA-7? know.
CITFA inherently difficult analyze sub-        ACKNOWLEDGMENTS
units, lack sequence similarity mammalian yeast RNA        grateful Barbara Burleigh (Harvard University) providing T.
pol transcription factors, lack known sequence motifs.      cruzi genomic DNA Sung Hee Park help generating Mechanistically, RNA pol transcription initiation conserved         anti-CITFA-6 immune serum. yeast mammals (28). involves formation            project funded NIH grant R01 AI059377  G.).
RNA pol transcription preinitiation complex (PIC),                                                                          REFERENCES
core promoter-binding factor recruits RNA pol transcrip-
                                                                          1. Brandenburg J, et al. 2007. Multifunctional class transcription tion initiation site interaction enzyme-bound               Trypanosoma brucei depends novel protein complex. EMBO J. 26:
factor RRN3. yeast, factor termed core factor,            4856 â€“ 4866.
humans termed SL1. addition, distinct factor            2. Brun R, Blum J. 2012. Human African trypanosomiasis. Infect. Dis. Clin.
binds upstream promoter element activates ribosomal                North  26:261â€“273.
                                                                          3. Chaves  et al. 1998. Subnuclear localization active variant surface
DNA (rDNA) transcription stabilizing PIC formation.                                                                              glycoprotein gene expression site Trypanosoma brucei. Proc. Natl. Acad.
VSG ES promoter extends 67 bp upstream transcrip-                Sci. U. S.  95:12328 â€“12333.
tion initiation site consists short sequence elements          4. Ehlers B, Czichos J, Overath P. 1987. RNA turnover Trypanosoma
(24, 34). elements required efficient binding          brucei. Mol. Cell. Biol. 7:1242â€“1249.
purified CITFA (1) close initiation site,    5. Grummt  Skinner JA. 1985. Efficient transcription protein-coding
                                                                             gene RNA polymerase promoter transfected cells. Proc. Natl.
CITFA appears functional equivalent yeast core              Acad. Sci. U. S.  82:722â€“726.
factor human SL1. According known functions           6. GÃ¼nzl  2010. pre-mRNA splicing machinery trypanosomes:
factors, CITFA-7 directly involved DNA binding                  complex simplified? Eukaryot. Cell 9:1159 â€“1170.
interact RRN3-like factor.  think          7. GÃ¼nzl  2012. RNA polymerases transcription factors trypano-
                                                                             somes, p 1â€“27. Bindereif (ed), RNA metabolism trypanosomes, vol case. Previously, able inhibit transcrip-
                                                                             28. Springer Press, Berlin, Germany.
tional function RNA pol II transcription factor TFIIB           8. GÃ¼nzl  Bindereif  Ullu E, Tschudi C. 2000. Determinants cap
adding polyclonal anti-TFIIB antibody extract prior            trimethylation U2 small nuclear RNA conserved vitro transcription reaction (30). RNA Pol II PIC formation            Trypanosoma brucei higher eukaryotic organisms. Nucleic Acids Res.
requires TFIIB bind promoter, TATA-binding pro-                28:3702â€“3709.
                                                                          9. GÃ¼nzl  Vanhamme L, Myler PJ. 2007. Transcription trypanosomes:
tein, polymerase, appears antibody able           different means end, p 177â€“208. Barry JD, Mottram JC, Mc-
interfere interactions. function CITFA sim-            Culloch R, Acosta-Serrano (ed), Trypanosomes genome.
ilarly inhibited antibody CITFA-2 (1)           Horizon Press, Pittsburgh, PA.



1580   ec.asm.org                                                                                                                         Eukaryotic Cell
                                                                                                                                  Novel CITFA Subunit T. brucei



10. Heix J, Zomerdijk JC, Ravanpay  Tjian R, Grummt  1997. Cloning              24. Pham VP, Qi CC, Gottesdiener KM. 1996. detailed mutational analysis
    murine RNA polymerase specific TAF factors: conserved interactions             VSG gene expression site promoter. Mol. Biochem. Parasitol. 75:
    subunits species-specific transcription initiation factor        241â€“254.
    TIF-IB/SL1. Proc. Natl. Acad. Sci. U. S.  94:1733â€“1738.                       25. Roditi  Clayton C. 1999. unambiguous nomenclature major
11. Hertz-Fowler C, et al. 2008. Telomeric expression sites highly              surface glycoproteins procyclic form Trypanosoma brucei. Mol.
    served Trypanosoma brucei. PLoS 3:e3527. doi:10.1371/                        Biochem. Parasitol. 103:99 â€“100.
    journal.pone.0003527.                                                           26. Rudenko G, Chung HM, Pham VP, Van der Ploeg LH. 1991. RNA
12. Kawahara T, et al. 2008. essential MYST-family proteins display                 polymerase mediate expression CAT neo protein-coding
    distinct roles histone H4K10 acetylation telomeric silencing try-         genes Trypanosoma brucei. EMBO J. 10:3387â€“3397.
    panosomes. Mol. Microbiol. 69:1054 â€“1068.                                       27. Ruepp S, et al. 1997. Survival Trypanosoma brucei tsetse fly 13. Kelly S, Wickstead B, Gull K. 2005. silico analysis trypanoso-             enhanced expression specific forms procyclin. J. Cell Biol.
    matid RNA polymerases: insights unusual transcription.                   137:1369 â€“1379.
    Biochem. Soc. Trans. 33:1435â€“1437.                                              28. Russell J, Zomerdijk JC. 2005. RNA-polymerase directed rDNA tran-
14. Laufer G, Schaaf G, BollgÃ¶nn S, GÃ¼nzl  1999. vitro analysis                 scription, life works. Trends Biochem. Sci. 30:87â€“96.
    alpha-amanitin-resistant transcription rRNA, procyclic acidic          29. Schimanski B, Brandenburg J, Nguyen TN, Caimano MJ, GÃ¼nzl 
    repetitive protein, variant surface glycoprotein gene promoters              2006. TFIIB-like protein indispensable spliced leader RNA gene
    Trypanosoma brucei. Mol. Cell. Biol. 19:5466 â€“5473.                                 transcription Trypanosoma brucei. Nucleic Acids Res. 34:1676 â€“1684.
15. Luz Ambrosio D, et al. 2009. Spliceosomal proteomics Trypanosoma             30. Schimanski B, Nguyen TN, GÃ¼nzl  2005. Characterization multi-
    brucei reveal new RNA splicing factors. Eukaryot. Cell 8:990 â€“1000.                 subunit transcription factor complex essential spliced-leader RNA
16. Marcello L, Barry JD. 2007. Analysis VSG gene silent archive                                                                                         gene transcription Trypanosoma brucei. Mol. Cell. Biol. 25:7303â€“7313.
    Trypanosoma brucei reveals mosaic gene expression prominent                                                                                     31. Schimanski B, Nguyen TN, GÃ¼nzl  2005. Highly efficient tandem
    antigenic variation favored archive substructure. Genome Res.
                                                                                        affinity purification trypanosome protein complexes based nove